These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14226831)

  • 21. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS.
    BARDOS TJ; DATTA-GUPTA N; HEBBORN P; TRIGGLE DJ
    J Med Chem; 1965 Mar; 8():167-74. PubMed ID: 14335145
    [No Abstract]   [Full Text] [Related]  

  • 22. [THE INFLUENCE OF PRELIMINARY TREATMENT OF RATS WITH ALKYLATING SUBSTANCES AND OTHER TOXINS ON THE GROWTH OF YOSHIDA SARCOMA].
    SCHMAEHL D; SATTLER W
    Arzneimittelforschung; 1964 Jul; 14():746-50. PubMed ID: 14344711
    [No Abstract]   [Full Text] [Related]  

  • 23. REACTION OF SOME MUTAGENIC AND CARCINOGENIC COMPOUNDS WITH NUCLEIC ACIDS.
    Brookes P; Lawley PD
    J Cell Comp Physiol; 1964 Oct; 64():SUPPL 1:111-27. PubMed ID: 14218578
    [No Abstract]   [Full Text] [Related]  

  • 24. [ACTION OF MYLERAN AND DEMI-MYLERAN (EMS) ON THE MUTATION OF STREPTOMYCIN RESISTANCE IN E. COLI K-12)].
    VERLY WG; BARBASON H; PETITPAS-DEWANDRE A; FREDERICQ P
    Life Sci (1962); 1964 Jul; 3():795-801. PubMed ID: 14203981
    [No Abstract]   [Full Text] [Related]  

  • 25. INDUCTION OF K12(LAMBDA) BY ALKYLATING AGENTS.
    LOVELESS A; SHIELDS G
    Virology; 1964 Dec; 24():668-9. PubMed ID: 14240418
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on chemical carcinogens and mutagens. XXXV. Standardization of mutagenic capacities of several common alkylating agents based on the concentration-time integrated dose.
    Hakura A; Mizuno Y; Goto M; Kawazoe Y
    Chem Pharm Bull (Tokyo); 1986 Feb; 34(2):775-80. PubMed ID: 3518970
    [No Abstract]   [Full Text] [Related]  

  • 27. Discrimination of mutagenic intermediates derived from alkylating agents by mutational patterns generated in Escherichia coli.
    Elespuru RK; Stupar LL; Gordon JA
    Carcinogenesis; 1991 Jul; 12(7):1161-7. PubMed ID: 2070480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CYTOSTATIC THERAPY WITH ALKYLATING AGENTS FOR MALIGNANT TUMORS].
    SCHUMACHER K; LANGE J
    Dtsch Med J; 1964 Nov; 15():761-5. PubMed ID: 14329920
    [No Abstract]   [Full Text] [Related]  

  • 29. [TUMOR INHIBITORY, HEMATOLOGICAL AND TOXICOLOGICAL EFFECTS OF 1,6-DIBROMO-1,6-DIDESOXY-D-MANNITOL].
    CSANYI E; HORVATH PI; INSTITORIS L
    Arzneimittelforschung; 1964 Jun; 14():670-3. PubMed ID: 14249065
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of some chemical mutagens and carcinogens on nucleic acids.
    Lawley PD
    Prog Nucleic Acid Res Mol Biol; 1966; 5():89-131. PubMed ID: 5337700
    [No Abstract]   [Full Text] [Related]  

  • 31. CHEMOTHERAPY OF BRAIN TUMORS. I. TRANSPLANTED MURINE EPENDYMOBLASTOMAS.
    SOLOWAY AH; MARK VH; DUKAT EG; KJELLBERG RN
    Cancer Chemother Rep; 1964 Mar; 36():1-4. PubMed ID: 14152269
    [No Abstract]   [Full Text] [Related]  

  • 32. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 33. STUDIES ON THE MECHANISM OF ACTION OF CYCLOPHOSPHAMIDE AND AB-132 WITH THE AID OF RADIOPROTECTIVE AGENTS.
    BACK N; BARDOS TJ; CHMIELEWICZ ZF; ACHTER E; MUNSON AE
    Life Sci (1962); 1964 Aug; 3():803-8. PubMed ID: 14201688
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of radiomimetic substances on deoxyribonucleic acid synthesis and function studies in Escherichia coli/phage systems. I. The nature of the inactivation of T2 phage in vitro by certain alkylating agents.
    LOVELESS A; STOCK JC
    Proc R Soc Lond B Biol Sci; 1959 Apr; 150(940):423-45. PubMed ID: 13645640
    [No Abstract]   [Full Text] [Related]  

  • 35. THE MUTAGENIC ACTIVITY OF DIETHYL SULPHATE IN DROSOPHILA MELANOGASTER. 3. THE SENSITIVITY OF THE IMMATURE (LARVAL) AND ADULT OVARY.
    PELECANOS M; ALDERSON T
    Mutat Res; 1964 Oct; 106():302-9. PubMed ID: 14234978
    [No Abstract]   [Full Text] [Related]  

  • 36. HISTOLOGICAL AND HISTOCHEMICAL DATA ON THE PROCESS OF REGRESSION OF EXPERIMENTAL TUMOURS INDUCED BY ALKYLATING AGENTS.
    PRESNOV MA
    Acta Unio Int Contra Cancrum; 1964; 20():126-30. PubMed ID: 14151866
    [No Abstract]   [Full Text] [Related]  

  • 37. EXPERIMENTAL STUDY OF OLIVOMYCIN, AN ANTITUMOUR ANTIBIOTIC.
    CHORIN VA; ROSSOLIMO OK; GOLDBERG LE; STANISLAVSKAYA MS; BLUMBERG NA; VERTOGRADOVA TP
    Acta Unio Int Contra Cancrum; 1964; 20():289-90. PubMed ID: 14151910
    [No Abstract]   [Full Text] [Related]  

  • 38. STUDIES ON ANTITUMOR SUBSTANCES. IV. ANTITUMOR EFFECT OF DIMETHANESULFONYL THIOALKANES.
    HAYASHI S; UEKI H; KOMIYA J
    Gan; 1964 Aug; 55():289-96. PubMed ID: 14215317
    [No Abstract]   [Full Text] [Related]  

  • 39. [ON THE ACUTE AND CHRONIC TOXICITY OF COTININE, AND ON ITS CANCERIGENIC EFFECT IN THE RAT].
    TRUHAUT R; DE CLERCQM M; LOISILLIER F
    Pathol Biol; 1964 Jan; 12():39-42. PubMed ID: 14133424
    [No Abstract]   [Full Text] [Related]  

  • 40. AZASERINE AND THIOPURINES. I. INHIBITION OF S-180 MOUSE TUMOR AND ANTIBODY SYNTHESIS.
    HANSEN HJ; VANDEVOORDE JP; BENNETT KJ; GILES WG; NADLER SB
    J Lab Clin Med; 1964 May; 63():801-18. PubMed ID: 14158063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.